Long-term visual results after vitrectomy for diabetic retinopathy;Langzeitverlauf des Visus nach Vitrektomie bei diabetischer Retinopathie

Ophthalmologe

Volumn 94, Issue 4, 1997, Pages 268-272

  Helbig, Horst ^a   Kellner, Ulrich ^a   Bornfeld, Norbert ^a   Foerster, Michael H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

diabetic retinopathy; long term follow up; vitrectomy

Indexed keywords

ADULT; ARTICLE; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY;

ADULT; AGED; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETINA; VISUAL ACUITY; VITRECTOMY;

EID: 0030993743     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050111     Document Type: Article

References (20)

1. Algvere P, Franzén G, Wiklund P (1987) Visual and social benefits of vitreous surgery in diabetics. A long-term follow-up evaluation. Acta Ophthalmol (Copenh) 65: 363-368
2. Blankenship GW (1981) Stability of pars plana vitrectomy results for diabetic retinopathy complications; a comparison of five-year and six-month postvitrectomy findings. Arch Ophthalmol 99: 1009-1012
3. Blankenship GW, Machemer R (1985) Long-term diabetic vitrectomy results. Report of 10 year follow up. Ophthalmology 92: 503-506
4. Diabetic retinopathy vitrectomy study research group (1988) Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial - diabetic retinopathy vitrectomy study report 3. Ophthalmology 95: 1307-1320
5. Diabetic retinopathy vitrectomy study research group (1990) Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: diabetic retinopathy vitrectomy study report S. Arch Ophthalmol 108: 958-964
6. Foerster MH, Esser J, Laqua H (1985) Silicone oil and its influence on electrophysiologic findings. Am J Ophthalmol 99: 201-206
7. Gabel VP, Beck P (1990) Verbessert Silikonöl die Prognose bei schwerer proliferativer diabetischer Retinopathie? Klin Monatsbl Augenheilkd 197: 112-117
8. Gnad HD, Freyler H, Klemen UM, Radda TM (1981) Spätergehnisse der Pars plana-Vitrektomie bei Diabetikern. Klin Monatsbl Augenheilkd 179: 508-511
9. Helbig H, Kellner U, Bornfeld N, Foerster MH (1996) Grenzen und Möglichkeiten der Glaskörper-Chirurgie bei diabetischer Retinopathie. Ophthalmologe 93: 647-654
10. Kellner U, Foester MH (1988) Effekt von flüssigem Silikon auf die Sehnervenfunktion. Fortschr Ophthalmol 85: 562-564
11. Laatikainen L, Summanen P (1989) Long-term visual results of vitreous surgery in diabetic eye disease. Acta Ophthalmol (Copenh) 67: 21-29
12. Laqua H, Lucke K, Foerster MH (1988) Entwicklung und gegenwärtiger Stand der Silikonölchirurgie. Klin Monatsbl Augenheilkd 192: 277-283
13. Lucke K, Laqua H (1991) Visusentwicklung nach Silikonchirurgie. Fortschr Ophthalmol 88: 603-607
14. Machemer R, Buettner H, Norton EWD, Parel JM (1971) Vitrectomy, a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 75: 813-820
15. Michels RG (1981) Proliferative diabetic retinopathy: pathophysiology of extraretinal complications and principles of vitreous surgery. Retina 1: 1-17
16. Nakazawa M, Kimizuka Y, Watabe T, Kato K, Watanabe H, Yamanobe S, Arakawa A, Tamai M (1993) Visual outcome after vitrectomy for diabetic retinopathy. A five-year follow-up. Acta Ophthalmol (Copenh) 71. 219-223
17. Rice TA, Michels RG (1980) Long-term anatomic and functional results of vitrectomy for diabetic retinopathy. Am J Ophthalmol 90: 297-303
18. Silicone study group (1992) Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone study report 2. Arch Ophthalmol 110: 780-792
19. Stefansson E (1990) Oxygen and diabetic eye disease. Graefes Arch Clin Exp Ophthalmol 228: 120-123
20. Ulbig MW, Kampik A, Hamilton AMP (1993) Diabetische Retinopathie. Epidemiologie, Risikofaktoren und Stadieneinteilung. Ophthalmologe 90: 197-209